September 20th 2025
Catch up on the top radiology content of the past week.
September 20th 2025
September 19th 2025
Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Louisiana
View More
Radioligand Therapy 101: The Science Behind the Strategy
View More
Working Together: Overcoming Barriers to Optimize Outcomes in Patients Treated With Radioligand Therapy Through Multidisciplinary Care
View More
South Carolina Oncology Society
1 Session is Available!
View More
GU Tumor Board: Enhancing Prostate Cancer Outcomes – The Role of PSMA and Targeted Treatment Strategies
September 27, 2025
Register Now!
2026 International Symposium of Gastrointestinal Oncology (ISGIO)
October 2-3, 2026
Register Now!
Community Oncology Connections™: Beyond the Basics—Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Washington
View More
Community Oncology Connections™: Beyond the Basics— Revolutionizing Advanced Prostate Cancer Management With PSMA-Targeted Therapies | Montana and Wyoming
View More
Emerging Tau-Targeting Antibody for Alzheimer’s Disease Gets FDA Fast Track Designation
Preliminary research findings have shown that the investigational anti-microtubule binding region (MTBR) tau antibody etalanetug may help reduce a biomarker for brain tau pathophysiology and tau signals on positron emission tomography (PET).
Findings from a multivariable analysis revealed that increased pulse wave velocity-end of systole (PWV-ES), assessed with ultrafast ultrasound, was associated with more than double the cardiovascular risk in young individuals with no major cardiovascular risk factors.
In a recent interview with Diagnostic Imaging, Noa Antonissen, M.D., and Colin Jacobs, Ph.D., discussed new research findings demonstrating robust risk stratification with a CT-based deep learning model for lung nodules as well as a 39.4 percent reduction in false positives in comparison to traditional classification.
ScanLab Unveils New Signal-to-Noise Ratio (SNR) Calculator for MRI
Offering prospective SNR calculation derived from prescribed slices, the SNR Calculator reportedly facilitates a higher degree of accuracy with quantitative SNR values beyond that of calculators from device manufacturers.
Leading Breast Radiologists Discuss Rise of Breast Cancer Incidence in Women Under 40
In light of emerging research suggesting an increased incidence of breast cancer among women under the age of 40, breast radiologists discuss what they’re seeing in practice and emphasize increased vigilance to facilitate early detection.
Multicenter Study Finds Abbreviated MRI Non-Inferior to mpMRI for csPCa Detection
Abbreviated biparametric MRI demonstrated nearly equivalent detection rates for clinically significant and clinically insignificant prostate cancer as multiparametric MRI, according to research involving 22 centers in 12 countries.
For HER2-positive breast cancer patients with radiologic complete response on breast MRI after neoadjuvant chemotherapy (NAC), the absence of calcifications was associated with over a 13 percent higher positive predictive value (PPV) for pathologic complete response (pCR).
Emphysema on Chest CT Linked to Threefold Higher Risk for COPD Mortality in Next 25 Years
Researchers also found that low-dose chest CT detection of emphysema was associated with a 29 percent higher risk of all-cause mortality up to 25 years later, according to a study involving over 9,000 individuals with a history of smoking.